Reforming access to new medicines

The Individual Patient Treatment Request (IPTR) is Scotland’s named patient programme scheme, which can allow access to treatments not routinely available on the NHS to patients with exceptional circumstances. Improvements to the system have been trialled through a Peer Approved Clinical System (PACS), which is set to replace the IPTR system from February 2018.

The system will focus on patient outcomes, introducing a peer review approach whereby for accessing medicines that have not been recommended by SMC, based on the anticipated clinical outcome for individual patients, giving clinicians a bigger say in the approval for treatments. While each health board will operate PACS Tier 2 for their own area, a new National Appeal Panel will be introduced, for individual requests for access to medicines not approved by the Scottish Medicines Consortium.

Read the full press release here.

Tagged with

Published 20. November 2017 in News UK